NNC-0640
CAS No. 307986-98-7
NNC-0640( —— )
Catalog No. M20735 CAS No. 307986-98-7
NNC-0640 is a negative allosteric modulator of Human Glucagon Receptor with an IC50 of 69.2 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 2MG | 56 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 163 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 445 | In Stock |
|
| 100MG | 641 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNNC-0640
-
NoteResearch use only, not for human use.
-
Brief DescriptionNNC-0640 is a negative allosteric modulator of Human Glucagon Receptor with an IC50 of 69.2 nM.
-
DescriptionNNC-0640 is a negative allosteric modulator of Human Glucagon Receptor with an IC50 of 69.2 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
Recptorhuman glucagon receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number307986-98-7
-
Formula Weight573.67
-
Molecular FormulaC29H31N7O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (435.79 mM)
-
SMILESCS(=O)(=O)c1cccc(NC(=O)N(Cc2ccc(cc2)C(=O)Nc2nn[nH]n2)c2ccc(cc2)C2CCCCC2)c1
-
Chemical Name4-[1-(4-Cyclohexylphenyl)-3-(3-methanesulfonylphenyl)ureidomethyl]-N-(2H-tetrazol-5-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Song G Yang D Wang Y et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators[J]. Nature 2017.
molnova catalog
related products
-
Avexitide acetate
Avexitide acetate (exendin 9-39) is a potent glucagon-like peptide 1 receptor (GLP-1R) antagonist for the study of post-obesity hypoglycemia.
-
Exenatide
Exenatide (Exendin-4) is a 39-aa peptide, highly potent, long-acting glucagon-like peptide-1 receptor (GLP-1) agonist with IC50 of 3.22 nM.
-
Tirzepatide
Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
Cart
sales@molnova.com